Bone Solutions closed a funding round for a total of >US $1.7MM, and affirmed an additional $1.65MM commitment from Next Health, its distribution partner.
Anika Therapeutics announced Canada launch of CINGAL® viscosupplement, cleared to treat knee osteoarthritis pain. CINGAL will be marketed by Pendopharm.
Johnson & Johnson is collaborating with a subsidiary of HP on use of 3D printing technologies to develop patient-customized products that can be manufactured quickly.
Mazor Robotics entered into strategic agreements with Medtronic for equity investment and for co-development/potential global distribution of certain Mazor products.Â
Novastep signed an agreement with Vivex Biomedical to launch bioSTART® Tissue Repair products, offering amniotic membranes and liquid to support foot and ankle procedures in the U.S.
Bone Therapeutics announced positive efficacy results for the 2nd patient cohort in its Phase I/IIA trial of ALLOB® allogeneic bone cell therapy product for the treatment of delayed-union fractures.
Zimmer Biomet closed its previously-announced acquisition of Cayenne Medical, a manufacturer of soft tissue repair and reconstruction products for the knee, shoulder and extremities.